These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 1697651

  • 1. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Bentvelsen FM, Bogdanowicz JF, Oosterom R, Schröder FH.
    Ned Tijdschr Geneeskd; 1990 Aug 18; 134(33):1596-600. PubMed ID: 1697651
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF, Bentvelsen FM, Oosterom R, Schroeder FH.
    Scand J Urol Nephrol Suppl; 1991 Aug 18; 138():97-103. PubMed ID: 1723815
    [Abstract] [Full Text] [Related]

  • 3. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A, Simşek F, Ilker Y, Türkeri L, Ercan H.
    Int Urol Nephrol; 1993 Aug 18; 25(3):271-8. PubMed ID: 7693607
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Mar 18; 46(3):333-42. PubMed ID: 9156044
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Feb 18; 46(2):145-54. PubMed ID: 9135695
    [Abstract] [Full Text] [Related]

  • 6. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J, de Torres Mateos JA.
    Arch Esp Urol; 1989 Feb 18; 42 Suppl 2():124-30. PubMed ID: 2484148
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate.
    Barak M, Mecz Y, Lurie A, Gruener N.
    J Lab Clin Med; 1989 May 18; 113(5):598-603. PubMed ID: 2469756
    [Abstract] [Full Text] [Related]

  • 8. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
    Théodon P, Rymer JC, Chopin D, Kouyoudjian JC, Abbou CC, Auvert J.
    Ann Urol (Paris); 1988 May 18; 22(3):199-205. PubMed ID: 2456713
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
    Pagani F, Zambolin T, Bonora R, Panteghini M.
    J Nucl Med Allied Sci; 1990 May 18; 34(4 Suppl):85-7. PubMed ID: 1709211
    [Abstract] [Full Text] [Related]

  • 10. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports].
    Amiel J, Chevallier D, Peyrottes A, Benoliel J, Toubol J.
    Ann Urol (Paris); 1989 May 18; 23(6):528-30. PubMed ID: 2482700
    [Abstract] [Full Text] [Related]

  • 11. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1988 Aug 18; 34(8):1389-96. PubMed ID: 2461644
    [Abstract] [Full Text] [Related]

  • 12. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S, Skaarland E, Halvorsen OJ, Stensland E, Farstad M.
    Tidsskr Nor Laegeforen; 1990 Sep 30; 110(23):2990-3. PubMed ID: 1700496
    [Abstract] [Full Text] [Related]

  • 13. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E.
    N Engl J Med; 1987 Oct 08; 317(15):909-16. PubMed ID: 2442609
    [Abstract] [Full Text] [Related]

  • 14. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E.
    Hinyokika Kiyo; 1996 Oct 08; 42(10):795-804. PubMed ID: 8951478
    [Abstract] [Full Text] [Related]

  • 15. [Prostatic diseases: tumor markers (PAP and PSA) and age at risk].
    Manna A, Trasatti L, Cifaldi L, Marchei GG, Reale MG, Marchei P.
    J Nucl Med Allied Sci; 1990 Oct 08; 34(4 Suppl):91. PubMed ID: 1709213
    [No Abstract] [Full Text] [Related]

  • 16. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E, Mari Ruiz M, Molina Andreu E.
    Arch Esp Urol; 1993 Mar 08; 46(2):99-103. PubMed ID: 7684585
    [Abstract] [Full Text] [Related]

  • 17. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay].
    Akino H, Tsuka H, Okada K, Tsuchiya Y, Matsubara M, Arimura K.
    Hinyokika Kiyo; 1995 Jun 08; 41(6):439-45. PubMed ID: 7544063
    [Abstract] [Full Text] [Related]

  • 18. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.
    Tarle M.
    Anticancer Res; 1988 Jun 08; 8(4):569-72. PubMed ID: 2460018
    [Abstract] [Full Text] [Related]

  • 19. [Prostate-specific antigen. A new marker of prostatic pathology].
    Boccon-Gibod L, Géraud M, Dugué MA.
    Ann Urol (Paris); 1988 Jun 08; 22(3):206-10. PubMed ID: 2456714
    [Abstract] [Full Text] [Related]

  • 20. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.
    Mulders TM, Bruning PF, Bonfrer JM.
    Eur J Surg Oncol; 1990 Feb 08; 16(1):37-41. PubMed ID: 1689677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.